Ultragenyx Reports Fourth Quarter and Full-Year 2014 Financial Results and Corporate Update
Go back to Ultragenyx Reports Fourth Quarter and Full-Year 2014 Financial Results and Corporate Update| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 29.06 +0.03 (0.10%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.03 | 52 Week High | $117.12 | |||
| Open | $28.58 | 52 Week Low | $46.52 | |||
| Day High | $29.39 | P/E | N/A | |||
| Day Low | $28.50 | EPS | $-1.97 | |||
| Volume | 488,006 | |||||
